Abstract
We previously reported that 28-day exposure to hepatocarcinogens that facilitate cell proliferation specifically alters the expression of G1/S checkpoint-related genes and proteins, induces aberrant early expression of ubiquitin D (UBD) at the G2 phase, and increases apoptosis in the rat liver, indicating G1/S and spindle checkpoint dysfunction. The present study aimed to determine the time of onset of carcinogen-specific cell-cycle disruption after repeated administration of renal carcinogens for up to 28 days. Rats were orally administered the renal carcinogens nitrofurantoin (NFT), 1-amino-2,4-dibromoantraquinone (ADAQ), and 1,2,3-trichloropropane (TCP) or the non-carcinogenic renal toxicants 1-chloro-2-propanol, triamterene, and carboxin for 3, 7 or 28 days. Both immunohistochemical single-molecule analysis and real-time RT-PCR analysis revealed that carcinogen-specific expression changes were not observed after 28 days of administration. However, the renal carcinogens ADAQ and TCP specifically reduced the number of cells expressing phosphorylated-histone H3 at Ser10 in both UBD(+) cells and proliferating cells, suggestive of insufficient UBD expression at the M phase and early transition of proliferating cells from the M p...Continue Reading
References
Jul 1, 1996·Genes & Development·D CobrinikT Jacks
Apr 16, 1998·Environmental Health Perspectives·W C Eastin
Feb 1, 2000·Journal of Cellular Physiology·T Scholzen, J Gerdes
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Sep 10, 2002·Trends in Biochemical Sciences·Lindsey D Mayo, David B Donner
Apr 20, 2005·Oncogene·David Cobrinik
Jul 19, 2005·Cancer Cell·Beth A A Weaver, Don W Cleveland
Oct 7, 2005·Virchows Archiv : an International Journal of Pathology·K J SchmitzH A Baba
Oct 14, 2005·Nature·Toru HirotaJan-Michael Peters
Sep 9, 2006·Cell Division·Chuan-Bian LimCaroline G L Lee
Oct 31, 2006·Archives of Dermatological Research·Riikka MattilaStina Syrjänen
Nov 17, 2006·The Journal of Biological Chemistry·Maria MalmlöfUlla Stenius
May 15, 2007·Circulation Research·Joerg HerrmannAmir Lerman
Aug 22, 2009·Carcinogenesis·Martijs J JonkerMirjam Luijten
Nov 10, 2009·Seminars in Cancer Biology·David W Meek, Ted R Hupp
Mar 14, 2012·Archives of Toxicology·Eriko TaniaiMakoto Shibutani
Jun 1, 2012·Kidney International·Bairbre A McNicholas, Matthew D Griffin
Dec 5, 2012·The Journal of Toxicological Sciences·Eriko TaniaiMakoto Shibutani
Feb 16, 2013·Archives of Toxicology·Atsunori YafuneMakoto Shibutani
Mar 20, 2013·Cellular and Molecular Life Sciences : CMLS·Mallikarjun PatilZheng Dong
Mar 29, 2013·Toxicology Letters·Atsunori YafuneMakoto Shibutani
Sep 23, 2014·The Journal of Toxicological Sciences·Hiroshi MatsumotoMasahiro Takeyoshi
Sep 23, 2014·The Journal of Toxicological Sciences·Ko OmuraTetsuro Urushidani
Nov 26, 2014·Proceedings of the National Academy of Sciences of the United States of America·Steven Setiawan ThengCaroline G Lee
Mar 17, 2015·Toxicology·Aki KijimaTakashi Umemura
May 27, 2015·Journal of Applied Toxicology : JAT·Masayuki KimuraMakoto Shibutani
Nov 13, 2015·The Journal of Toxicological Sciences·Masayuki KimuraMakoto Shibutani